Table 3.
Patient distribution (validation cohort) | |||
---|---|---|---|
All (%) | Resectable | Unresectable | |
n | 16 | 7 | 9 |
Sex | |||
Male | 10 (62.5) | 3 | 7 |
Female | 6 (37.5) | 4 | 2 |
Age | |||
Mean | 69 | 67 | 70 |
Min–Max | 53–83 | 58–71 | 53–83 |
Other cancers | |||
No | 11 (68.75) | 4 | 7 |
Yes | 5 (31.25) | 3 | 2 |
Tumor location | |||
Head | 5 (31.25) | 3 | 2 |
Undefined | 2 (12.5) | 0 | 2 |
Body | 2 (12.5) | 1 | 1 |
Tail | 7 (43.75) | 3 | 4 |
Specimen type | |||
Primary tumor | 13 (81.25) | 7 | 6 |
Hepatic metastasis | 2 (12.5) | 0 | 2 |
Carcinomatosis | 1 (6.25) | 0 | 1 |
Tumor status at diagnosis | |||
Localized | 7 (43.75) | 7 | 0 |
Locally advanced | 1 (6.25) | 0 | 1 |
Metastasis | 6 (37.5) | 0 | 6 |
Carcinomatosis | 2 (12.5) | 0 | 2 |